AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aly, H. E.
Right arrow Articles by Simpson, M. H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aly, H. E.
Right arrow Articles by Simpson, M. H. W.
Agricola
Right arrow Articles by Aly, H. E.
Right arrow Articles by Simpson, M. H. W.

American Journal of Clinical Nutrition, Vol 24, 297-303, Copyright © 1971 by The American Society for Clinical Nutrition, Inc.

Oral contraceptives and vitamin B6 metabolism

Hekmat E. Aly Ph.D.1, Elizabeth A. Donald Ph.D.2, and Mary H. W. Simpson M.S.3

1 Department of Environmental Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York 11203
2 Associate Professor, School of Household Economics, University of Alberta, Edmonton 7, Alberta, Canada
3 Present address: Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada

Five young women who were taking oral contraceptive pills, and five young women who were not, consumed a diet of known composition for 6 days. On the morning of the 6th day a fasting blood sample was taken, followed by the administration of a 2-g load dose of l-tryptophan. Continuous 24-hr urine samples were collected and composited so that days 1-4 were pooled, whereas samples from day 5 and day 6 were considered to be the preload sample and the postload sample. Urine was analyzed for XA, KA, K, and OH-K, and for vitamin B6. The fasting blood sample was analyzed for plasma amino acid levels and the amount of GOT and GPT in the erythrocytes.

The levels of the tryptophan metabolites excreted on days 1-4 compared with that collected on day 5 were not statistically different for either the control or experimental group. Urinary XA increased after taking the dose of tryptophan in both the control and experimental subjects and this increase was significant at a P < 0.001 for the experimental group. Increases were also noted posttryptophan for KA and K again for both groups of subjects. The higher levels of tryptophan metabolites observed preload in the control subjects have been attributed to the effect of endogenous steroid production as the load dose was administered at the point of ovulation. It has been postulated that the greater affinity of the transaminase enzymes for vitamin B6 than that of the kynureninase enzymes might account for the increased amounts of XA and KA in the experimental subjects. The excretion of OH-K was similar in both groups.

The excretion of vitamin B6 in the urine was not significantly changed throughout the study. The slight decrease noted posttryptophan could be an adaptation of subjects to a diet containing slightly less vitamin B6 than in the usual diet consumed.

The levels of the essential amino acids in the plasma of the experimental subjects were significantly lower for phenylalanine and methionine compared with control subjects. There was no significant difference between groups for the levels of threonine, lysine, leucine, or isoleucine, although the levels of lysine, leucine, and isoleucine were lower for the experimental subjects.

The levels of the nonessential amino acids analyzed, except histidine and aspartic acid, were lower in the experimental subjects compared with control subjects. This difference was highly significant for glycine, proline, arginine, and tyrosine.

The total essential amino acids were not significantly different between groups but the total nonessential amino acids were significant at a P < 0.002.

The GOT levels in the red blood cell were statistically higher in the experimental group than the control group. This difference was also evident when the enzyme system was activated by the in vitro addition of pyridoxal phosphate. The GPT levels in the erythrocyte were the same for both groups.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. S. Morris, M. F. Picciano, P. F Jacques, and J. Selhub
Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. H. N. Golden
The Development of Concepts of Malnutrition
J. Nutr., July 1, 2002; 132(7): 2117S - 2122.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by The American Society for Nutrition